A GROUP of parents whose children's deaths were linked to Dengvaxia vaccine said that the Department of Justice (DOJ) has ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...

Each year at the J.P. Morgan Healthcare Conference, pharma CEOs are tasked with assuring and convincing investors that they’ve positioned their companies to overcome expected challenges.

CEOs of some of the largest drugmakers said this week they were encouraged after Trump said at a meeting with pharma executives late last year that these middlemen need to be eliminated.

The Impact of the US Biosecure Act on Global Pharma Manufacturing The US Biosecure Act has significant implications for the global pharmaceutical supply chain. By restricting Chinese companies ...

For Fierce Pharma's day 1 news roundup, click here. Fierce Biotech's day 1 coverage can be found here. Below, check out the latest coverage from day 2, including a wrap-up of the scene outside of ...

Phio Pharmaceuticals shares more than tripled after the company said it saw positive results from its Phase 1b trial for its cancer treatment PH-762. Shares were recently up more than 270% to $6. ...

“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice president for ...

In 2025, pharma companies must enable an instantaneous data-to-decision value chain that is AI-powered, cloud-based, and product-enabled. You need to ingest data rapidly, manage it, keep it ...

The stakes are clear. Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 billion by streamlining the resource- and time ...